Hrt Financial LP T2 Biosystems, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.15 - $0.54 $5,353 - $19,273	-35,692 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $668 - $1,059	-1,858 Reduced 4.95%	35,692 $18,000
Q4 2021 Feb 14, 2022	BUY	$0.46 - $0.94 $17,273 - $35,297	37,550 New	37,550 $19,000
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $8,974 - $12,626	-10,435 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $424,688 - $690,118	-408,354 Reduced 97.51%	10,435 $12,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $303,126 - $870,339	229,641 Added 121.41%	418,789 $678,000
Q4 2020 Feb 16, 2021	BUY	$1.06 - $1.51 $200,496 - $285,613	189,148 New	189,148 $234,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.